Lactadherin is a widely distributed glycoprotein (~ 50 kDa), which was originally characterized due to its association with milk fat/lipid globule membranes. Synonymous names are PAS-6/7, bovine-associated mucoprotein, BA-46, P47, and MFG-E8. Structural hallmarks of lactadherin are the presence of two epidermal growth factor (EGF) homology domains (with an RGD peptide motif in the second EGF domain), and two C domains sharing homology with the discoidin family of lectin domains including the phospholipid-binding domains of blood clotting factors V and VIII. Lactadherin shows preferential binding to phosphatidylserine (L-form) in a calcium independent manner, and binds more specifically than Annexin V.

Purified lactadherin functions as an anticoagulant by blocking phosphatidylserine-containing membrane sites for blood coagulation proteins (10). Fluoresence-labeled lactadherin functions as a sensitive probe for exposed phosphatidylserine on nucleated cells and on stimulated platelets (8, 9) . Lactadherin will bind to membranes that have phosphatidylserine content below the threshold for annexin V binding.

Lactadherin is purified from un-pasteurized bovine milk (11).

Illustrated Applications

Above: K562 cells (top) and HL60 cells (bottom) co-stained with both FITC-conjugated lactadherin (green) and Alexa-647 conjugated annexin V (red) early in apoptosis. The annexin is internalized in granules and is not detectably staining the cells. Reference: Shi, J., Y. Shi, L. N. Waehrens, J. T. Rasmussen, C. W. Heegaard and G. E. Gilbert (2006). "Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells undergoing programmed cell death." Cytometry A 69(12): 1193-201. Copyright 2006. John Wiley & Sons, Inc. Reprinted with permission of John Wiley & Sons, Inc.

Above: HeLa cells stained with FITC-conjugated lactadherin 2 hours (top) and 3 hours (bottom) after treatment with staurosporine. Early in apoptosis the cells have small vesicles and long, thin appendages that stain avidly for lactadherin. Reference: Waehrens LN, Heeghaard, CW, Gilbert GE, Rasmussen JT. Bovine Lactadherin as a Calcium-independent Imaging Agent of Phosphatidylserine Expressed on the Surface of Apoptotic HeLa Cells 2009 J. Histochem. Cytochem. (ePub June 2009).

Above: Phosphatidylserine exposure in mouse mesenteric venous thrombosis. Mice were given 1 µg each of lactadherin and annexin V by tail vein immediately prior to externalization of the mesentery. The mesentary was exposed to ferric chloride and then the animals were perfused with saline/paraformaldehyde. Serial sections of the mesentary were stained with anti-fibrinogen/fibrin (left), anti-platelet (middle), and anti-lactadherin antibodies (right) developed with the alkaline phosphatase Vector Red substrate. A layer of fibrinogen/fibrin (left, closed arrows) overlaid a mural hemorrhage (open star). Platelets (middle) were scattered along the luminal surface of the thrombus (open triangles) as well as upon fibrinogen/fibrin strands extending into the lumen. Lactadherin staining (right) was strongest along the raised endothelium surface (closed arrow), including adherent platelets close to the wall. Platelets on fibrin strands did not stain detectably (open arrow). (Shi J, Pipe SW, Rasmussen JT, Heegaard CW, Gilbert GE. Lactadherin blocks thrombosis and hemostasis in vivo: correlation with platelet phosphatidylserine exposure. J Thromb Haemost. Jul 2008;6(7):1167-1174).

Guidelines for using BLAC-FITC:

FITC-conjugated bovine lactadherin (BLAC-FITC) is supplied as a 100X stock solution (1.6 micromolar) in a buffer of 20mM Tris, 150mM NaCl, pH 7.4 containing 1% (w/v) bovine serum albumin and 0.02% sodium azide. Assuming that most labeling reaction volumes will be approximately 0.5ml, a 1 ml vial of the 100X stock material will be sufficient for 200 labeling reactions. Additionally, as this product is fluorescently labeled it should be protected from light.

For a typical cell staining experiment, apoptotic cells are collected by centrifugation and resuspended in a physiologic buffer such as TBS (20mM Tris, 150mM NaCl, pH 7.4), HBS (20mM Hepes, 150mM NaCl, pH 7.4) or PBS (4.3mM Na₂HPO₄, 1.47mM KH₂PO₄, 137mM NaCl, 2.7 mM KCL, pH 7.4) to a final cell count of approximately 1 x 10⁶ cells/ml. Adherent cells may be harvested by trypsinization, but should be washed at least once in either media or buffer prior to making the final suspension in buffer. Stock 100X FITC-conjugated lactadherin is added to the cell suspension at the rate of 5 microliters for every 0.5ml of the cell suspension. At this point, optional staining with propidium iodide (PI) may be initiated by adding PI to a final concentration of 0.5 to 1 µg/ml. Incubate the reaction mixture at room temperature (protected from light) for a period of 5 to 10 minutes.

Labeled cells may be analyzed by a variety of methods including flow cytometry and fluorescence microscopy. Fluorescence detection may be monitored using the following detector settings:

BLAC-FITC: Ex = 488 nm; Em = 530 nm

PI: Ex = 488 nm; Em = 640 nm

Haemtech生物制药服务（HBS）是一家领先的，符合cGMP要求的QC测试实验室，专门为生产重组和血浆衍生蛋白疗法的生物制药制造商提供分析服务，重点是那些会影响止血系统的药物。HBS使客户能够满足法规和质量测试要求，从而将其候选药物从开发转向商业化。

对生物制药的需求正在增长，并且该行业正在迅速采用外包策略，以作为满足不断升级的监管要求的一种方式。凭借在止血方面的丰富经验，HBS能够很好地协助开发影响凝血系统的药物产品。